The Schain Research team is growing and we are very excited to announce that Dr Malin Almgren will take over the CEO role as of today. Malin will work in close collaboration with the former CEO and Founder Frida Schain, PhD who will transition into a new role as active Chairman of the Board of Directors. Together with the other Board members Lars Johansson and Malin Heyman, Frida will focus on strategic work and the establishment of new external partnerships. This is an important step as we continue to expand our capabilities and expertise to serve our clients in the RWE and Data Science field.
Malin Almgren, Assistant Professor, has a PhD in Medicine from Karolinska Institutet and comes most recently from a position as a financial advisor, supporting M&A transactions in the healthcare sector at Experia Corporate Finance Advisors AB. Initially, Malin will work in parallel with Frida Schain to ensure good business continuity.
Great to have you on board Malin, welcome!